D30.8
Benign neoplasm of other specified urinary organs
Clinical Classification Guidelines
Inclusion Terms
- Benign neoplasm of paraurethral glands
Medical Intelligence & Overview
Benign neoplasms are non-cancerous growths that develop in various parts of the body, including the urinary organs. The ICD-10 code D30.8 refers to benign tumors affecting specific urinary organs not categorized elsewhere, including the paraurethral glands. These growths are usually not life-threatening but can cause discomfort or other health issues. Recognizing their nature, causes, symptoms, and treatment options helps in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Uncontrolled cell growth in the urinary organs, possibly due to genetic factors Chronic inflammation or irritation in the urinary tract Hormonal influences affecting glandular tissue History of urinary tract infections or other urinary system issues Genetic predisposition to benign tumor development Environmental factors and exposure to certain chemicals or toxins Age-related changes in tissue proliferation
Key Symptoms: Usually painless, but some individuals may experience discomfort Presence of a palpable lump or mass in the affected area Local swelling or enlargement of the urinary organ involved Possible urinary symptoms such as frequent urination or urgency if the tumor affects urinary flow Rarely, bleeding or discharge if the tumor irritates surrounding tissue Asymptomatic in many cases, detected incidentally during examinations
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign neoplasm in the urinary organs involves several steps:
Treatment Protocols: Management of benign neoplasms in the urinary organs varies based on size, location, and symptoms:
Clinical Advice & FAQs
Billing Guidance
Is D30.8 a billable ICD-10 code?
Yes, D30.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D30.8?
Clinical documentation must specify the nature of Benign neoplasm of other specified urinary organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
